A screen of FDA-approved drugs identifies inhibitors of protein tyrosine phosphatase 4A3 (PTP4A3 or PRL-3)

por Rivas, Dylan R., Dela Cerna, Mark Vincent C., Smith, Caroline N., Sampathi, Shilpa, Patty, Blaine G., Lee, Donghan, Blackburn, Jessica S.
Publicado 2021

Inhibition of mitochondrial fission activates glycogen synthesis to support cell survival in colon cancer

por Hasani, Sumati, Young, Lyndsay E. A., Van Nort, Warren, Banerjee, Moumita, Rivas, Dylan R., Kim, Jinhwan, Xiong, Xiaopeng, Sun, Ramon C., Gentry, Matthew S., Sesaki, Hiromi, Gao, Tianyan
Publicado 2023